<?xml version="1.0" encoding="UTF-8"?>
<document id="29483281">
	<sentence id="s1" text="Chronic l-DOPA treatment that induces dyskinesia selectively restores spine density and excitability in indirect pathway SPNs (iSPNs), whereas spine loss and hyperexcitability persist in direct pathway SPNs (dSPNs).">
		<entity id="s1.e1" charOffset="38-48"
			type="HP" text="dyskinesia" ontology_id="HP_0100660"/>
		<entity id="s1.e2" charOffset="121-124"
			type="GENE" text="SPN" ontology_id="10522"/>
		<pair id="s1.p1" e1="s1.e1"
		    e2="s1.e2" pgr="true"/>
	</sentence>
	<sentence id="s2" text="This indicates that dopamine-mediated synaptic remodeling and plasticity is independent of dopamine innervation during SPN development and that Pitx3-/- mice are a good model because they develop the same pathology described in the toxins-based models and in human postmortem studies of advanced PD.SIGNIFICANCE STATEMENT As the only genetic model of Parkinson*s disease (PD) that develops dyskinesia, Pitx3-/- mice reproduce the behavioral effects seen in humans and are a good system for studying dopamine-induced synaptic remodeling.">
		<entity id="s2.e1" charOffset="119-122"
			type="GENE" text="SPN" ontology_id="10522"/>
		<entity id="s2.e2" charOffset="144-149"
			type="GENE" text="Pitx3" ontology_id="5309"/>
		<entity id="s2.e3" charOffset="390-400"
			type="HP" text="dyskinesia" ontology_id="HP_0100660"/>
		<pair id="s2.p1" e1="s2.e3"
		    e2="s2.e3" pgr="false"/>
		<pair id="s2.p2" e1="s2.e1"
		    e2="s2.e3" pgr="true"/>
	</sentence>
	<sentence id="s3" text="Pitx3-/- mice reproduced the alterations described in patients with advanced PD and in well accepted toxin-based models of PD and dyskinesia.">
		<entity id="s3.e1" charOffset="0-5"
			type="GENE" text="Pitx3" ontology_id="5309"/>
		<entity id="s3.e2" charOffset="130-140"
			type="HP" text="dyskinesia" ontology_id="HP_0100660"/>
		<pair id="s3.p1" e1="s3.e1"
		    e2="s3.e2" pgr="false"/>
	</sentence>
</document>
